Jenna R. Karras

Immunology and Microbiology · Life Sciences

8h-index214citations24works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(13), Chemokine receptors and signaling(11), Immune cells in cancer(10), Genetics and Neurodevelopmental Disorders(7), DNA Repair Mechanisms(4)

Publications24 total

Supplementary Figure 1 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Supplementary Figure 2 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Data from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Supplementary Figure 2 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Supplementary Figure 3 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Data from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Supplementary Figure Legends from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Supplementary Figure 1 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Supplementary Figure 3 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Supplementary Figure 4 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Supplementary Figure 4 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Supplementary Figure Legends from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
2023Open Access
Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
Cancer Immunology Research·2019· 64 citedOpen Access
Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms·2017· 13 citedOpen Access
Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch
Advances in Biological Regulation·2016· 16 citedOpen Access
Fhit loss‐associated initiation and progression of neoplasia <i>in vitro</i>
Cancer Science·2016· 9 citedOpen Access
Exome‐wide single‐base substitutions in tissues and derived cell lines of the constitutive Fhit knockout mouse
Cancer Science·2016· 15 citedOpen Access
Fhit inactivation in neoplasia: in vitro insights into cancer initiation and progression
2016
Subject Index Vol. 150, No. 3-4, 2016
Cytogenetic and Genome Research·2016
Title Page / Table of Contents
Cytogenetic and Genome Research·2016Open Access
page 1 of 2Next →

Frequent Co-authors

Emilio Sanseviero(13), Erin M. O’Brien(13), Tamer B. Shabaneh(13), Bülent Arman Aksoy(13), Cathy Zheng(13), Xiangfan Yin(13), Giorgos C. Karakousis(13), Ravi K. Amaravadi(13), Brian Nam(13), Mary Jo Turk(13), Jeff Hammerbacher(13), Mark P. Rubinstein(13), Lynn M. Schuchter(13), Tara C. Mitchell(13), Qin Liu(13), Erica L. Stone(13), Xiaowei Xu(12), Kay Huebner(8), Wei Xu(8), Morgan S. Schrock(6)